Hansen, K. S., Mogensen, T. H., Agergaard, J., Schiøttz-Christensen, B., Østergaard, L., Vibholm, L. K. & Leth, S. (2023). High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. The Lancet Regional Health - Europe, 24, [100539]. https://doi.org/10.1016/j.lanepe.2022.100539

Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., O’Farrelly, C., Novelli, G., Rodríguez-Gallego, C., Haerynck, F., Prando, C., Pujol, A., Casanova, J. L. & COVID Human Genetic Effort (2022). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 23(2), 159-164. https://doi.org/10.1038/s41590-021-01030-z

Rise, N., Touborg, T., Lundsted, D. H., Dalager-Pedersen, M. & Mogensen, T. H. (2022). Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton’s agammaglobulinemia. Frontiers in Immunology, 13, [1057065]. https://doi.org/10.3389/fimmu.2022.1057065

Wiggers, I. & Mogensen, T. H. (2022). Genetisk og immunologisk baggrund for herpes implex-encefalitis. Ugeskrift for Læger, 184(16), [V11210879]. https://ugeskriftet.dk/videnskab/genetisk-og-immunologisk-baggrund-herpes-simplex-encefalitis

Paludan, S. R. & Mogensen, T. H. (2022). Innate immunological pathways in COVID-19 pathogenesis. Science Immunology, 7(67), [eabm5505]. https://doi.org/10.1126/sciimmunol.abm5505

Duncan, C. J. A., Skouboe, M. K., Howarth, S., Hollensen, A. K., Chen, R., Børresen, M. L., Thompson, B. J., Stremenova Spegarova, J., Hatton, C. F., Stæger, F. F., Andersen, M. K., Whittaker, J., Paludan, S. R., Jørgensen, S. E., Thomsen, M. K., Mikkelsen, J. G., Heilmann, C., Buhas, D., Øbro, N. F. ... Mogensen, T. H. (2022). Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. The Journal of Experimental Medicine, 219(6), [e20212427]. https://doi.org/10.1084/jem.20212427

Freytag, M. R., Jørgensen, S. E., Thomsen, M. M., Al-Mousawi, A., Hait, A. S., Olagnier, D., Bay, J. T., Helleberg, M. & Mogensen, T. H. (2022). Postpartum Disseminated Herpes Simplex Virus Type 1 Infection With Hemophagocytic Lymphohistiocytosis and Fulminant Neonatal Herpes Infection. The Journal of Infectious Diseases, 225(1), 157-162. https://doi.org/10.1093/infdis/jiab290

Brodin, P., Casari, G., Townsend, L., O’Farrelly, C., Tancevski, I., Löffler-Ragg, J., Mogensen, T. H., Casanova, J. L. & The COVID Human Genetic Effort (2022). Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nature Medicine, 28, 879-882. https://doi.org/10.1038/s41591-022-01766-7

Mogensen, T. H., Skouboe, M. K. & Mølle, I. (2022). Successful use of interferon alfa-2a for persistent parvovirus B19 infection. Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(22)00685-5

Manry, J., Bastard, P., Gervais, A., Le Voyer, T., Rosain, J., Philippot, Q., Michailidis, E., Hoffmann, H. H., Eto, S., Garcia-Prat, M., Bizien, L., Parra-Martínez, A., Yang, R., Haljasmägi, L., Migaud, M., Särekannu, K., Maslovskaja, J., de Prost, N., Tandjaoui-Lambiotte, Y. ... CoV-Contact Cohort (2022). The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proceedings of the National Academy of Sciences of the United States of America, 119(21), [e2200413119]. https://doi.org/10.1073/pnas.2200413119